论文部分内容阅读
目的探讨治疗时间对高压氧联合阿昔洛韦治疗病毒性脑膜炎临床治愈率的影响。方法选取该院2012年4月-2014年5月收治的病毒性脑膜炎患者288例,发病时间在72h以上192例作为对照组,发病时间在72h以内96例作为观察组。比较2组患者的临床疗效。结果观察组的治愈率41.67%明显高于对照组的29.17%,总有效率为100.00%也明显高于对照组的80.21%,差异均有统计学意义(P<0.05)。结论高压氧联合阿昔洛韦治疗病毒性脑膜炎疗效显著,安全可靠,值得在临床中推广应用,且病程越短,治疗越及时,疗效越好。
Objective To investigate the effect of treatment time on clinical cure rate of viral meningitis with hyperbaric oxygen combined with acyclovir. Methods A total of 288 patients with viral meningitis who were treated in our hospital from April 2012 to May 2014 were selected. 192 patients with onset of disease over 72h served as control group and 96 patients with onset of disease within 72h as observation group. The clinical effects of two groups were compared. Results The cure rate in observation group was significantly higher than that in control group (41.67% vs 29.17%, the total effective rate was 100.00%), which was significantly higher than that in control group (80.21%, P <0.05). Conclusions Hyperbaric oxygen combined with acyclovir in the treatment of viral meningitis is significant, safe and reliable, which is worth popularizing in clinical practice. The shorter the course of the disease is, the more timely the treatment is and the better the curative effect is.